Autopsy report · NCT02534883

Cervical Ripening in Postmenopausal Women

“not able to meet enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

St. Louis University

Sponsor type

University, hospital or other

Conditions

Stenosis of Cervix

Interventions

Misoprostol; Placebo

Participants

11

Sites

1

Countries

United States

Trials that died the same way

• CD19 Redirected Autologous T Cells for Hodgkin Lymphoma
  “unable to meet enrollment goal” (89% match in meaning)
• Ambulatory Blood Pressure and the Normal Increase in Maternal Blood Pressure Postpartum
  “Unable to enroll” (88% match in meaning)
• Hearing Resources and Outcomes in the Emergency Department (HERO-ED)
  “Did not meet enrollment” (87% match in meaning)
• BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
  “Insufficient enrollment” (87% match in meaning)
• Mechanical vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions
  “Unable to meet enrollment goals” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.